Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Instem appoints former PAREXEL luminary as COO

MaryBeth Thompson has more than 18 years of experience in the life sciences industry
Management appointment
Prior to PAREXEL, Thompson worked for AstraZeneca and Wyeth-Ayerst Laboratories

Life sciences industry veteran MaryBeth Thompson has been appointed as chief operating officer of Instem Plc (LON:INS), the clinical trials software services provider.

Thompson will report to chief executive officer Phil Reason, but will not sit on the board.

She has more than 18 years of experience in the life sciences industry, with a primary focus in regulatory affairs and operations with a demonstrable track record as a leader and builder of outsourcing services businesses, Instem said.

Thompson previously worked at PAREXEL International, the multi-national life sciences consulting firm, where she established and expanded the regulatory outsourcing services practice from a US$1 million revenue business with 30 employees to an international organisation across the US, Europe and India with more than US$30 million of revenues and 300 employees.

“We are delighted to have appointed someone of MaryBeth's calibre and experience to Instem,” said Reason.

“MaryBeth has a strong track record in building life sciences businesses and we look forward to the benefits she will bring as we embark upon the company's next phase of growth," the CEO added.

John-H.jpg
Why Invest In Instem Plc? Read More Here

Register here to be notified of future INS Company articles
View full INS profile View Profile

Instem Plc Timeline

Big Picture
September 19 2016

Related Articles

Tablet computers
November 22 2016
As smartphones are portable and always connected, consumers are able to respond to stimuli from their environment in real-time
picture of keyboard
December 05 2016

e-commerce specialist blur reported a more than doubling of project bookings on its online platform last year.

BOSGLOBAL.jpg
December 21 2016
BOS spies a huge opportunity for 360 and so will focus all its efforts and financial firepower on the product.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use